Imax Corp has a consensus price target of $22.19, established from looking at the 49 latest analyst ratings. The last 3 analyst ratings were released from Barrington Research, Wedbush, and Barrington Research on March 4, 2024, March 4, 2024, and February 28, 2024. With an average price target of $23.33 between Barrington Research, Wedbush, and Barrington Research, there's an implied 44.39% upside for Imax Corp from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
03/04/2024 | IMAX | Buy Now | Imax | $16.16 | 48.51% | Barrington Research | James Goss | → $24 | Reiterates | Outperform → Outperform | Get Alert |
03/04/2024 | IMAX | Buy Now | Imax | $16.16 | 36.14% | Wedbush | Alicia Reese | → $22 | Reiterates | Outperform → Outperform | Get Alert |
02/28/2024 | IMAX | Buy Now | Imax | $16.16 | 48.51% | Barrington Research | James Goss | → $24 | Reiterates | Outperform → Outperform | Get Alert |
02/28/2024 | IMAX | Buy Now | Imax | $16.16 | 36.14% | Wedbush | Alicia Reese | → $22 | Reiterates | Outperform → Outperform | Get Alert |
02/23/2024 | IMAX | Buy Now | Imax | $16.16 | 36.14% | Wedbush | Alicia Reese | → $22 | Reiterates | Outperform → Outperform | Get Alert |
02/13/2024 | IMAX | Buy Now | Imax | $16.16 | 54.7% | Rosenblatt | Steve Frankel | $30 → $25 | Maintains | Buy | Get Alert |
02/06/2024 | IMAX | Buy Now | Imax | $16.16 | 5.2% | JP Morgan | David Karnovsky | $20 → $17 | Maintains | Neutral | Get Alert |
01/18/2024 | IMAX | Buy Now | Imax | $16.16 | 36.14% | Benchmark | Mike Hickey | $24 → $22 | Maintains | Buy | Get Alert |
01/11/2024 | IMAX | Buy Now | Imax | $16.16 | -19.55% | Goldman Sachs | Mike Burton | $15 → $13 | Maintains | Sell | Get Alert |
01/02/2024 | IMAX | Buy Now | Imax | $16.16 | 29.95% | B. Riley Securities | Eric Wold | $27 → $21 | Maintains | Buy | Get Alert |
12/05/2023 | IMAX | Buy Now | Imax | $16.16 | 85.64% | Rosenblatt | Steve Frankel | → $30 | Reiterates | Buy → Buy | Get Alert |
10/10/2023 | IMAX | Buy Now | Imax | $16.16 | 85.64% | Rosenblatt | Steve Frankel | → $30 | Reiterates | Buy → Buy | Get Alert |
10/09/2023 | IMAX | Buy Now | Imax | $16.16 | 48.51% | Benchmark | Mike Hickey | $23 → $24 | Maintains | Buy | Get Alert |
08/25/2023 | IMAX | Buy Now | Imax | $16.16 | 85.64% | Rosenblatt | Steve Frankel | $27 → $30 | Maintains | Buy | Get Alert |
08/18/2023 | IMAX | Buy Now | Imax | $16.16 | 85.64% | Rosenblatt | Steve Frankel | $27 → $30 | Maintains | Buy | Get Alert |
07/28/2023 | IMAX | Buy Now | Imax | $16.16 | 48.51% | Barrington Research | James Goss | → $24 | Reiterates | Outperform → Outperform | Get Alert |
07/27/2023 | IMAX | Buy Now | Imax | $16.16 | 60.89% | Wedbush | Alicia Reese | → $26 | Reiterates | Outperform → Outperform | Get Alert |
07/27/2023 | IMAX | Buy Now | Imax | $16.16 | 85.64% | Rosenblatt | Steve Frankel | $27 → $30 | Maintains | Buy | Get Alert |
07/20/2023 | IMAX | Buy Now | Imax | $16.16 | 60.89% | Wedbush | Alicia Reese | → $26 | Reiterates | Outperform → Outperform | Get Alert |
The latest price target for Imax (NYSE: IMAX) was reported by Barrington Research on March 4, 2024. The analyst firm set a price target for $24.00 expecting IMAX to rise to within 12 months (a possible 47.92% upside). 32 analyst firms have reported ratings in the last year.
The latest analyst rating for Imax (NYSE: IMAX) was provided by Barrington Research, and Imax reiterated their outperform rating.
The last upgrade for Imax Corp happened on April 23, 2021 when Wedbush raised their price target to $26. Wedbush previously had a neutral for Imax Corp.
The last downgrade for Imax Corp happened on June 2, 2021 when Goldman Sachs changed their price target from $19.6 to $18.6 for Imax Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Imax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Imax was filed on March 4, 2024 so you should expect the next rating to be made available sometime around March 4, 2025.
While ratings are subjective and will change, the latest Imax (IMAX) rating was a reiterated with a price target of $0.00 to $24.00. The current price Imax (IMAX) is trading at is $16.23, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.